These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 25267802

  • 1. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, Raj SR, Robertson D, Biaggioni I.
    Hypertension; 2014 Dec; 64(6):1241-7. PubMed ID: 25267802
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 3. Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial.
    Lewin A, Lasseter KC, Dong F, Whalen JC.
    J Am Soc Hypertens; 2012 Apr; 6(3):228-36. PubMed ID: 22421631
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA, Basile J, Stapff M, Khan B, Zhou D.
    J Clin Hypertens (Greenwich); 2012 Sep 31; 14(9):588-92. PubMed ID: 22947356
    [Abstract] [Full Text] [Related]

  • 9. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE, DiGennaro F, Giani JF, Dominici FP.
    Vasc Health Risk Manag; 2012 Sep 31; 8():151-60. PubMed ID: 22454559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 31; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 13. Cyclic guanosine monophosphate modulation and blood pressure.
    Jordan J.
    Hypertension; 2014 Dec 31; 64(6):1194-5. PubMed ID: 25267799
    [No Abstract] [Full Text] [Related]

  • 14. Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans.
    Price A, Raheja P, Wang Z, Arbique D, Adams-Huet B, Mitchell JH, Victor RG, Thomas GD, Vongpatanasin W.
    Hypertension; 2013 Jun 31; 61(6):1263-9. PubMed ID: 23547240
    [Abstract] [Full Text] [Related]

  • 15. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
    Briasoulis A, Oliva R, Kalaitzidis R, Flynn C, Lazich I, Schlaffer C, Bakris G.
    J Clin Hypertens (Greenwich); 2013 Jul 31; 15(7):473-9. PubMed ID: 23815535
    [Abstract] [Full Text] [Related]

  • 16. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.
    Acelajado MC, Pisoni R, Dudenbostel T, Oparil S, Calhoun DA, Glasser SP.
    J Am Soc Hypertens; 2012 Jul 31; 6(1):66-72. PubMed ID: 22024668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M, Matera MG, Ruggeri P, Sanduzzi A, Spicuzza L, Vatrella A, Girbino G.
    Respiration; 2004 Jan 15; 71(2):159-64. PubMed ID: 15031571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.